Table 5.

Alert signs for each EPA

EPA statementAlert signs
Diagnosing and assessing patients with hematological disorders Consistent inability to obtain clinical history using a logical anamnesis or physical examination
Repeatedly disregards relevant information from medical history
Frequently erases medical records 
Providing and implementing a therapeutic plan for patients facing benign hematological disorders Repeatedly disregards failures in previous treatments
Consistently ignores typical signs and symptoms of treatment toxicity
Consistently fails to implement measures to prevent and/or mitigate toxicity 
Providing and implementing a therapeutic plan for patients facing malignant hematological disorders Repeatedly disregards failures in previous treatments
Consistently ignores typical signs and symptoms of treatment toxicity
Consistently fails to implement measures to prevent and/or mitigate toxicity 
Managing and stratifying patients with urgent or emergent complications of hematological disorders Repeatedly fails to identify patients who require emergency care
Consistently ignores the relevance of stratification systems and/or critical tests for decision-making 
Recommending suitable patients for HSCT Repeatedly disregards HSCT as part of the therapeutic plan, when indicated 
Recommending and implementing palliative care for ineligible patients for curative care Consistently ignores the concept of palliative care when evaluating patients ineligible for curative care
Fully ignores the tenets of contemporary palliative care 
Providing systematic follow-up for patients with chronic hematological disorders Repeatedly fails to identify and monitor critical parameters required for the follow-up for patients with chronic diseases
Repeatedly fails to provide high quality information regarding potential complications and alert signs 
Providing continuous and progressive care for survivors of hematological cancer Consistently ignores complications inherent to survivors of hematological cancer
Fails to inform patients and relatives about long-term risks associated with hematological cancer treatment 
Recommending transfusion therapy and managing their complications Consistently prescribes transfusions based on outdated indications
Ignores signs or symptoms of transfusion reactions and consistently fails to implement preventive and/or treatment measures
Consistently ignores regulations involved in transfusion medicine practice 
Recommending therapeutic apheresis, assessing and managing their complications Consistently prescribes apheresis procedures based on outdated indications
Ignores signs or symptoms of apheresis complications and consistently fails to implement preventive and/or treatment measures 
Supervising blood donation procedure Ignores legislation and clinical criteria for blood donation, consistently failing to perform donor screening and/or communication with the public
Fails to implement basic procedures aimed to guarantee blood donor safety 
Consulting patients with hematological manifestations of systemic disorders Consistently fails to obtain clinical and laboratory data that are relevant to provide hematological consultation for other specialties
Consistently fails to understand needs and questions in consultation requests 
Communicating with patients and relatives Consistently fails to communicate with patients, families, and other health care professionals to a level that puts patient safety at risk
Consistently uses hostile or discriminatory language/behavior toward patients, relatives, caregivers, and/or coworkers
Consistently fails to adequately register patient data in medical records 
Synthetizing, reporting, and registering clinical cases and information for peers and different audiences Consistently fails to organize a clinical history in a logical and clear fashion when discussing with peers, either by omitting essential data or overemphasizing noncritical information 
Cooperating with coworkers as leader or as team member Consistently fails to communicate with other health care professionals
Repeated demonstrations of difficulties when performing in a team
Ignores basic aspects of how health systems are organized to a level that jeopardizes treatment planning and/or patient safety
Consistently ignores ethical standards of practice 
Performing bone marrow procedures Ignores basic technical aspects of the procedure
Does not recognize signs or symptoms of complications
Repeated negative feedback from patients, relatives, and/or coworkers about any aspect of the procedure 
Recognizing, interpreting, and reporting cytological findings in peripheral blood and bone marrow smears Consistently fails to identify critical alterations in laboratory results
Ignores basic technical aspects of these tests to a level that jeopardizes clinical interpretation 
Recommending and interpreting immunophenotyping and molecular tests for patients with hematological disorders Ignores clinical impact of molecular-based essays, missing opportunities for proper use, or overusing/overinterpreting them
Ignores basic technical aspects of these assays to a level that jeopardizes clinical interpretation 
Recommending and interpreting other ancillary tests for patients with hematological disorders Ignores a basic portfolio of laboratory tests necessary to support the diagnostic work-up of blood disorders
Ignores basic technical aspects of these assays to a level that jeopardizes clinical interpretation 
Recommending and interpreting tests for patients under transfusion therapy Consistently fails to interpret even basic assays used in transfusion medicine
Ignores basic technical aspects of these assays to a level that jeopardizes clinical interpretation 
EPA statementAlert signs
Diagnosing and assessing patients with hematological disorders Consistent inability to obtain clinical history using a logical anamnesis or physical examination
Repeatedly disregards relevant information from medical history
Frequently erases medical records 
Providing and implementing a therapeutic plan for patients facing benign hematological disorders Repeatedly disregards failures in previous treatments
Consistently ignores typical signs and symptoms of treatment toxicity
Consistently fails to implement measures to prevent and/or mitigate toxicity 
Providing and implementing a therapeutic plan for patients facing malignant hematological disorders Repeatedly disregards failures in previous treatments
Consistently ignores typical signs and symptoms of treatment toxicity
Consistently fails to implement measures to prevent and/or mitigate toxicity 
Managing and stratifying patients with urgent or emergent complications of hematological disorders Repeatedly fails to identify patients who require emergency care
Consistently ignores the relevance of stratification systems and/or critical tests for decision-making 
Recommending suitable patients for HSCT Repeatedly disregards HSCT as part of the therapeutic plan, when indicated 
Recommending and implementing palliative care for ineligible patients for curative care Consistently ignores the concept of palliative care when evaluating patients ineligible for curative care
Fully ignores the tenets of contemporary palliative care 
Providing systematic follow-up for patients with chronic hematological disorders Repeatedly fails to identify and monitor critical parameters required for the follow-up for patients with chronic diseases
Repeatedly fails to provide high quality information regarding potential complications and alert signs 
Providing continuous and progressive care for survivors of hematological cancer Consistently ignores complications inherent to survivors of hematological cancer
Fails to inform patients and relatives about long-term risks associated with hematological cancer treatment 
Recommending transfusion therapy and managing their complications Consistently prescribes transfusions based on outdated indications
Ignores signs or symptoms of transfusion reactions and consistently fails to implement preventive and/or treatment measures
Consistently ignores regulations involved in transfusion medicine practice 
Recommending therapeutic apheresis, assessing and managing their complications Consistently prescribes apheresis procedures based on outdated indications
Ignores signs or symptoms of apheresis complications and consistently fails to implement preventive and/or treatment measures 
Supervising blood donation procedure Ignores legislation and clinical criteria for blood donation, consistently failing to perform donor screening and/or communication with the public
Fails to implement basic procedures aimed to guarantee blood donor safety 
Consulting patients with hematological manifestations of systemic disorders Consistently fails to obtain clinical and laboratory data that are relevant to provide hematological consultation for other specialties
Consistently fails to understand needs and questions in consultation requests 
Communicating with patients and relatives Consistently fails to communicate with patients, families, and other health care professionals to a level that puts patient safety at risk
Consistently uses hostile or discriminatory language/behavior toward patients, relatives, caregivers, and/or coworkers
Consistently fails to adequately register patient data in medical records 
Synthetizing, reporting, and registering clinical cases and information for peers and different audiences Consistently fails to organize a clinical history in a logical and clear fashion when discussing with peers, either by omitting essential data or overemphasizing noncritical information 
Cooperating with coworkers as leader or as team member Consistently fails to communicate with other health care professionals
Repeated demonstrations of difficulties when performing in a team
Ignores basic aspects of how health systems are organized to a level that jeopardizes treatment planning and/or patient safety
Consistently ignores ethical standards of practice 
Performing bone marrow procedures Ignores basic technical aspects of the procedure
Does not recognize signs or symptoms of complications
Repeated negative feedback from patients, relatives, and/or coworkers about any aspect of the procedure 
Recognizing, interpreting, and reporting cytological findings in peripheral blood and bone marrow smears Consistently fails to identify critical alterations in laboratory results
Ignores basic technical aspects of these tests to a level that jeopardizes clinical interpretation 
Recommending and interpreting immunophenotyping and molecular tests for patients with hematological disorders Ignores clinical impact of molecular-based essays, missing opportunities for proper use, or overusing/overinterpreting them
Ignores basic technical aspects of these assays to a level that jeopardizes clinical interpretation 
Recommending and interpreting other ancillary tests for patients with hematological disorders Ignores a basic portfolio of laboratory tests necessary to support the diagnostic work-up of blood disorders
Ignores basic technical aspects of these assays to a level that jeopardizes clinical interpretation 
Recommending and interpreting tests for patients under transfusion therapy Consistently fails to interpret even basic assays used in transfusion medicine
Ignores basic technical aspects of these assays to a level that jeopardizes clinical interpretation 

or Create an Account

Close Modal
Close Modal